Entos Pharmaceuticals Inc. is a clinical-stage genetic medicines company. A new reality in genetic medicine lies ahead, one that will be ushered in with the advent of safe, effective, and redosable nucleic acid delivery technologies. At Entos, we develop next generation genetic medicines using our proprietary Fusogenix proteolipid vehicle (PLV) drug delivery system. Fusogenix PLVs are formulated with FAST proteins to enable the delivery of nucleic acid into target cells through direct fusion.
Location: Canada, Alberta, Edmonton
Member count: 11-50
Founded date: 2016
Investors 1
| Date | Name | Website |
| - | Catalio Ca... | cataliocap... |
Mentions in press and media 1
| Date | Title | Description | Category | Author | Source |
| 06.01.2022 | Lilly and ... | INDIANAPOLIS and EDMONTON, AB,... | - | - | marketscre... |